Zai Lab (ZLAB) Retained Earnings (2016 - 2026)
Zai Lab's (ZLAB) quarterly Retained Earnings came in at $15.1 million in Q1 2026, down 69.36% year-on-year from $49.3 million in Q1 2025, and down 49.14% quarter-over-quarter from $29.7 million in Q4 2025.
Zai Lab (ZLAB) Retained Earnings (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Retained Earnings across 11 years of filings, most recently posting $15.1 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at $15.1 million, down 69.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.1 million (down 69.36% YoY), and the FY2025 annual result was $29.7 million, down 41.21% from the prior year.
- Retained Earnings came in at $15.1 million for Q1 2026 at Zai Lab, down from $29.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $52.2 million in Q2 2023 to a low of -$2.2 billion in Q1 2024.
- The 5-year median for Retained Earnings is $28.3 million (2024), against an average of -$455.8 million.
- Peak annual rise in Retained Earnings reached 1062.92% in 2023, while the deepest fall reached 8649.66% in 2023.
- Zai Lab's Retained Earnings stood at $25.7 million in 2022, then slumped by 8649.66% to -$2.2 billion in 2023, then jumped by 102.3% to $50.5 million in 2024, then plunged by 41.21% to $29.7 million in 2025, then plunged by 49.14% to $15.1 million in 2026.
- The last three Retained Earnings figures came in at $15.1 million (Q1 2026), $29.7 million (Q4 2025), and $39.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 15.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.11 Mn |
| Dec 31, 2025 | 29.70 Mn |
| Sep 30, 2025 | 39.65 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 49.30 Mn |
| Dec 31, 2024 | 50.52 Mn |
| Sep 30, 2024 | 28.27 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Mar 31, 2024 | -2.25 Bn |
| Dec 31, 2023 | -2.20 Bn |
| Sep 30, 2023 | 47.95 Mn |
| Jun 30, 2023 | 52.18 Mn |
| Mar 31, 2023 | -1.91 Bn |
| Dec 31, 2022 | 25.69 Mn |
| Sep 30, 2022 | -1.80 Bn |
| Jun 30, 2022 | 4.49 Mn |
| Mar 31, 2022 | -25.84 Mn |
| Dec 31, 2021 | -1.42 Bn |
| Sep 30, 2021 | -1.21 Bn |
| Jun 30, 2021 | -1.11 Bn |